OXYTOCIN AND CARBOPROST IN DELIVERY

OXYTOCIN AND CARBOPROST IN ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR - OXCARB

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/018908

Enrollment

242

Registered

2019-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Intramuscular carboprost: 125 mcg of Intramuscular Carboprost given in the anterolateral aspect of thigh of pregnant women within 1 minute of delivery of baby. Control Intervention1: In

Eligibility

Inclusion criteria

Inclusion criteria: Women with singleton pregnancy with cephalic presentation beyond 37 completed weeks of gestation in labour for vaginal Delivery.

Exclusion criteria

Exclusion criteria: 1. Traumatic PPH 2. Hypertensive disorders of pregnancy. 3. Anaemia (Hb 4. Multiple pregnancies 5. Polyhydramnios 6. Grand multipara 7. Bronchial Asthma 8. Macrosomia( > 4 kg). 9. Hypersensitivity to drugs. 10. Intrauterine fetal death.

Design outcomes

Primary

Measure	Time frame
To assess and compare the effectiveness of intramuscular oxytocin with intramuscular carboprost in the active management of third stage of labourTimepoint: From delivery of baby to before delivery of placenta.	—

Secondary

Measure	Time frame
To assess amount of blood loss during third stage of labour. Duration of third stage of labour Will be measured and additional oxytocics requirement and side effects of drug will be measured.Timepoint: Third stage of labour.	—

Countries

India

Contacts

Public Contactshanthisubramani

pondicherry institute of medical sciences

palolalbahadur@gmail.com9894744050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026